Cargando…

PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma

BACKGROUND: CXCR4 is a chemokine receptor frequently overexpressed in invasive breast cancer that has been shown to play a major role in signaling pathways involved in metastasis. The aim of this retrospective analysis was to assess the diagnostic performance of CXCR4-directed PET imaging in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vag, Tibor, Steiger, Katja, Rossmann, Andreas, Keller, Ulrich, Noske, Aurelia, Herhaus, Peter, Ettl, Johannes, Niemeyer, Markus, Wester, Hans-Jürgen, Schwaiger, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127070/ https://www.ncbi.nlm.nih.gov/pubmed/30191351 http://dx.doi.org/10.1186/s13550-018-0442-0

Ejemplares similares

Response assessment with the CXCR4-directed positron emission tomography tracer [(68)Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities
por: Herhaus, Peter, et al.
Publicado: (2017)

Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics
por: Habringer, Stefan, et al.
Publicado: (2018)

Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo — a comparison to [(68)Ga]pentixafor
por: Poschenrieder, Andreas, et al.
Publicado: (2016)

[(64)Cu]NOTA-pentixather enables high resolution PET imaging of CXCR4 expression in a preclinical lymphoma model
por: Poschenrieder, Andreas, et al.
Publicado: (2017)

CXCR4-directed theranostics in oncology and inflammation
por: Kircher, Malte, et al.
Publicado: (2018)

First (18)F-Labeled Pentixafor-Based Imaging Agent for PET Imaging of CXCR4 Expression In Vivo
por: Poschenrieder, Andreas, et al.
Publicado: (2016)

The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity
por: Poschenrieder, Andreas, et al.
Publicado: (2016)

Investigation of spleen CXCR4 expression by [(68)Ga]Pentixafor PET in a cohort of 145 solid cancer patients
por: Lewis, Richard, et al.
Publicado: (2021)

Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results
por: Noske, Aurelia, et al.
Publicado: (2019)

In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
por: Philipp-Abbrederis, Kathrin, et al.
Publicado: (2015)

A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency
por: Osl, Theresa, et al.
Publicado: (2020)

PET Imaging of Integrin αVβ3 Expression
por: Beer, Ambros J., et al.
Publicado: (2011)

Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL
por: Herrmann, Ken, et al.
Publicado: (2014)

Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging
por: Wester, Hans Jürgen, et al.
Publicado: (2015)

[(177)Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent
por: Schottelius, Margret, et al.
Publicado: (2017)

Exploring the Role of RGD-Recognizing Integrins in Cancer
por: Nieberler, Markus, et al.
Publicado: (2017)

PET Imaging of CXCR4 Receptors in Cancer by a New Optimized Ligand
por: Demmer, Oliver, et al.
Publicado: (2011)

CXCR4 PET imaging of mantle cell lymphoma using [(68)Ga]Pentixafor: comparison with [(18)F]FDG-PET
por: Mayerhoefer, Marius E., et al.
Publicado: (2021)

[(68)Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [(18)F]FDG and laboratory values
por: Lapa, Constantin, et al.
Publicado: (2017)

New imaging agents targeting chemokine receptor CXCR4 for PET/SPECT and MRI
por: Poty, Sophie, et al.
Publicado: (2014)

Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [(68)Ga]pentixafor PET/CT
por: Derlin, Thorsten, et al.
Publicado: (2018)

PET / MR as tool for ”precision medicine”
por: Schwaiger, Markus
Publicado: (2014)

Agonists for the Chemokine Receptor CXCR4
por: Lefrançois, Marilou, et al.
Publicado: (2011)

Non-Hodgkin Lymphoma Secondary to Hodgkin Lymphoma in an Adult Patient With Nijmegen Breakage Syndrome
por: Braitsch, Krischan, et al.
Publicado: (2018)

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
por: Litman-Zawadzka, Ala, et al.
Publicado: (2020)

Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma
por: Gockel, Ines, et al.
Publicado: (2006)

Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [(68)Ga]Ga-Pentixafor-PET/MRI
por: Haug, Alexander R., et al.
Publicado: (2019)

Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands
por: Moussouras, Natasha A., et al.
Publicado: (2017)

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
por: Shi, Yi, et al.
Publicado: (2020)

Regulation of the Chemokine Receptor CXCR4 by Hypoxia
por: Schioppa, Tiziana, et al.
Publicado: (2003)

Molecular Imaging of Chemokine Receptor CXCR4
por: Weiss, Ido. D., et al.
Publicado: (2013)

The Structure of a CXCR4:Chemokine Complex
por: Handel, Tracy Marie
Publicado: (2015)

Computer‐aided assessment of the chemokine receptors CXCR3, CXCR4 and CXCR7 expression in gallbladder carcinoma
por: Yu, Xiao, et al.
Publicado: (2020)

First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer
por: Ettl, Johannes, et al.
Publicado: (2020)

Chemokine Receptors, CXCR1 and CXCR2, Differentially Regulate Exosome Release in Hepatocytes
por: Nojima, Hiroyuki, et al.
Publicado: (2016)

Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
por: Chifu, Irina, et al.
Publicado: (2020)

CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas
por: Weich, Alexander, et al.
Publicado: (2021)

FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice
por: Yousefi, Behrooz H, et al.
Publicado: (2015)

[68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques
por: Li, Xiang, et al.
Publicado: (2017)

Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5
por: Schmutz, Caroline, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_5sqis65gh9glejlqq9k0j5n92j